Oxime-based anti-skinning additives—particularly methyl ethyl ketoxime (MEKO) and 2-Pentanone Oxime (2-PO)—have been widely used in alkyd formulations to prevent premature film formation in the can. However, increasing regulatory restrictions are accelerating the need for oxime-free alternatives.

In March 2022, the European Commission (ATP 15-part 3 Annex VI) concluded that MEKO will be classified as a Carcinogen Category 1B, with labeling required at ≥ 0.1% MEKO content.

2-PO is expected to receive a harmonized GHS Carcinogen 2 classification in the EU. 
Although regulations are shifting, performance expectations have not changed. 

This webinar introduces Borchers’ NEW Borchi^® Guard oxime-free anti-skin line that – compared to oxime-based solutions –provides:

•    Skin prevention at reduced dosages while maintaining favorable drying performance after application
 
•    Broad compatibility with various resin systems and drier packages

•    Improved regulatory compliance with reliable coating quality

Borchi^® Guard enables the transition to oxime-free alkyd systems without compromising performance.